These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35820683)

  • 1. Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study.
    Fakhraei R; Erwin E; Alibhai KM; Murphy MSQ; Dingwall-Harvey ALJ; White RR; Dimanlig-Cruz S; LaRose R; Grattan K; Jia JJ; Liu G; Arnold C; Galipeau Y; Shir-Mohammadi K; Alton GD; Dy J; Walker MC; Fell DB; Langlois MA; El-Chaâr D
    CMAJ Open; 2022; 10(3):E643-E651. PubMed ID: 35820683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
    Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
    J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
    Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
    JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.
    Atkinson A; Albert A; McClymont E; Andrade J; Beach L; Bolotin S; Boucoiran I; Bullard J; Charlton C; Crane J; Dougan S; Forest JC; German GJ; Giguère Y; Girouard G; Hankins C; Krajden M; Lang A; Levett P; Minion J; Neudorf C; Poliquin V; Robinson JL; Scott H; Stein DR; Tran V; Zahariadis G; Zhou HY; Money D;
    CMAJ Open; 2023; 11(2):E305-E313. PubMed ID: 37015743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
    McGuire SS; Klassen AB; Heywood J; Sztajnkrycer MD
    Prehosp Disaster Med; 2021 Apr; 36(2):131-134. PubMed ID: 33397545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
    Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
    CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.
    Gonik CO; Alonso AM; Gonik B
    Am J Perinatol; 2023 Jun; 40(8):912-916. PubMed ID: 34758496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychological impact of the COVID-19 pandemic and a SARS-CoV-2 testing programme on obstetric patients and healthcare workers.
    Ross AM; Ramlawi S; Fakhraei R; Murphy MS; Ducharme R; Dingwall-Harvey AL; White RR; Ritchie K; Muldoon K; El-Chaâr D
    Womens Health (Lond); 2022; 18():17455057221103101. PubMed ID: 35686846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.